RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA
Clinical trials for RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets recurrent brain tumors in kids
Disease control Recruiting nowThis early-stage trial is testing the safety and best dose of two drugs, trametinib and everolimus, given together to children and young adults whose gliomas (a type of brain tumor) have come back after previous treatment. The study aims to find the highest dose that is safe and …
Matched conditions: RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New MRI technique could reveal hidden brain tumor activity
Knowledge-focused Recruiting nowThis study tests a new type of MRI scan that uses a special substance (hyperpolarized 13C pyruvate) to see how brain tumors use energy. Researchers want to know if this scan is safe and can show changes in tumor metabolism over time. About 300 people with low-grade gliomas will b…
Matched conditions: RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA
Phase: PHASE1 • Sponsor: Susan Chang • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC